← Insiders

BWXT

Neutral signalScored 2026-10-20 Drivers: Congress, trend, fundamentals. Insiders: neutral. Moteurs : Congrès, tendance, fondamentaux. Initiés : neutre.

Research, not advice.

À propos

BWX Technologies, Inc.

Nom
BWX Technologies, Inc.
Secteur
Industrials
Industrie
Aerospace & Defense
Bourse
NYSE
Capitalisation
$11.7B
Employés
10,400
PDG
Rex D. Geveden
Site web
https://www.bwxt.com
Marché
BCKIYCWFISNGDHIILEU

BWX Technologies, Inc. operates globally, specializing in the production and sale of nuclear components across the United States, Canada, and other international regions. The company's multifaceted operations are categorized into three distinct segments: Nuclear Operations Group, Nuclear Power Group, and Nuclear Services Group. The Nuclear Operations Group is a pivotal supplier of precision naval and critical nuclear components, including reactors, nuclear fuel, and assemblies, primarily supporting the United States Department of Energy/National Nuclear Security Administration's Naval Nuclear Propulsion Program. This segment also fabricates missile launch tubes for U.S. Navy submarines, produces specialized close-tolerance equipment for various nuclear applications, and is involved in converting Cold War-era stockpiles of high-enriched uranium. Its responsibilities further extend to the receiving, storage, characterization, dissolution, recovery, and purification of uranium-bearing materials, alongside providing research reactor fuel elements for academic and national laboratories, and other defense-related components. The Nuclear Power Group caters to the commercial nuclear sector, offering a comprehensive range of products such as nuclear steam generators, fuel, fuel handling systems, pressure vessels, reactor components, heat exchangers, tooling delivery systems, and specialized containers. This group provides engineering and in-plant services for nuclear power facilities, overseeing the design, manufacturing, commissioning, and servicing of nuclear power generation equipment. It also delivers essential in-plant inspection, maintenance, and modification services, non-destructive examination, and tooling/repair solutions. Moreover, it is a key provider of medical radioisotopes and radiopharmaceuticals for research, diagnostic, and therapeutic applications. Finally, the Nuclear Services Group focuses on critical support functions, encompassing nuclear materials processing, environmental site remediation, and comprehensive management and operating services. This segment is also dedicated to advancing technology for nuclear power sources and plays a role in the design, engineering, licensing, and manufacturing of nuclear reactors. Founded in 1867 as The Babcock & Wilcox Company, the corporation adopted its current name, BWX Technologies, Inc., in June 2015, and is headquartered in Lynchburg, Virginia.

Price (1 year)

Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.

VENTE TOTALE: 10 000 titres (~1 712 147,00 $ US)

Insiders
Geveden Rex D
Total bought
—

Avg buy (VWAP, 90d window) —

Total sold
$452,985

Avg sell (VWAP, 90d window) $174.22 vs last close $131.20 (-24.7%)

Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.

$452,985 of that total is under a Rule 10b5-1 plan. It is shown here and left out of the score.

Last activity
2026-08-12
Liquidity
Liquid $164,816,517/day · 20d vol
Last synced
2026-10-26 21:10:12 Synced via automated research pipeline

Sign in to request a sync of this company's price history and timing levels.

Insider holdings as a share of total assets aren't available for this company.

Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.

Recent Form 4

Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.

Date Person Side Shares Price Value Form 4
2026-08-12 Geveden Rex D Sell · S · 10b5-1 2,600 $174.22 $452,985 Form 4

Sales marked 10b5-1 are scheduled in advance and don't count toward the Quorum score. Les ventes marquées 10b5-1 sont planifiées à l'avance et ne pèsent pas dans le score Quorum.

Congressional trades

STOCK Act disclosures (90-day window)

Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.

Date Member Side Amount range Filing
2026-08-03 April Delaney Buy $1,001 - $15,000 Filing
2026-07-30 April Delaney Buy $1,001 - $15,000 Filing
2026-07-27 April Delaney Buy $1,001 - $15,000 Filing
2026-07-24 April Delaney Buy $15,001 - $50,000 Filing

Recent trades

DateRepresentativeTypeAmount
2026-08-25April McClain DelaneySale$100,001 - $250,000
2026-08-03April McClain DelaneyPurchase$1,001 - $15,000
2026-07-30April McClain DelaneyPurchase$1,001 - $15,000
2026-07-27April McClain DelaneyPurchase$1,001 - $15,000
2026-07-24April McClain DelaneyPurchase$15,001 - $50,000
2026-05-15April McClain DelaneyPurchase$15,001 - $50,000
2026-05-14April McClain DelaneyPurchase$1,001 - $15,000
2026-05-08April McClain DelaneyPurchase$15,001 - $50,000
2026-05-07April McClain DelaneyPurchase$1,001 - $15,000
2025-10-31Lisa C. McClainSale (Full)$1,001 - $15,000
2025-10-30Lisa C. McClainSale (Full)$1,001 - $15,000
2025-10-30Lisa C. McClainPurchase$1,001 - $15,000
2025-06-11Lisa C. McClainPurchase$1,001 - $15,000
2023-09-08Lois FrankelSale (Full)$1,001 - $15,000
2023-06-28Lois FrankelSale (Partial)$1,001 - $15,000
2022-01-10Lois FrankelSale (Partial)$1,001 - $15,000
2021-12-10Lois FrankelPurchase$1,001 - $15,000
2018-11-14Lamar Seeligson SmithPurchase$1,001 - $15,000
2018-08-16Lamar Seeligson SmithPurchase$1,001 - $15,000

Signal

Neutral signalScored 2026-10-20 Drivers: Congress, trend, fundamentals. Insiders: neutral. Moteurs : Congrès, tendance, fondamentaux. Initiés : neutre.

BWXT combines strong liquidity (85) with a meaningful earnings catalyst (65) driven by raised 2026 guidance, naval contract momentum, and AI-driven nuclear demand, justifying a constructive stance.

The first sentence of the analysis written for BWXT on 2026-10-20 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.

Neutral signal Drivers: Congress, trend, fundamentals. Insiders: neutral. Moteurs : Congrès, tendance, fondamentaux. Initiés : neutre.

Factor checklist — research, not advice

A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.

  • Insider Unavailable or mixed. – Insider: neutral. All sales (≈ $453K) were pre-planned Rule 10b5-1 trades, excluded from the score. No open-market buys or discretionary sales. – Initiés : neutre. Toutes les ventes (≈ $453K) sont sous plan 10b5-1 préétabli, exclues du score. Aucun achat ni vente discrétionnaire.
  • Narrative Supports a bullish reading. Stored narrative reading is in the bullish band
  • Congress Unavailable or mixed. 8 purchase disclosures year to date, a thin reading
  • Timing Pulls against a bullish reading. Close is more than 0.5 ATR under stored support
  • Financial indicators Supports a bullish reading. Current ratio 2.32 · operating margin 10%

Suggested stop 123.60, 1.5 ATR under the last close(5.8% under the last close). Reward/risk to the next stored resistance is 3.58. Research, not advice. Not an order.

Recent news

Market snapshot

Financial ratios

MetricTrend2025-12-312024-12-312023-12-312022-12-312021-12-31
Gross Profit Margin22.9%24.2%24.9%24.7%25.9%
Ebit Margin13.8%14.4%14.8%15.7%20.3%
Ebitda Margin17.2%17.5%17.9%19.0%23.6%
Operating Profit Margin10.1%14.1%15.3%15.6%16.3%
Pretax Profit Margin12.4%12.9%12.9%14.1%18.6%
Continuous Operations Profit Margin10.3%10.4%9.9%10.7%14.4%
Net Profit Margin10.3%10.4%9.8%10.7%14.4%
Bottom Line Profit Margin10.3%10.4%9.8%10.7%14.4%
Current Ratio2.3221.9612.1812.0981.683
Quick Ratio2.2531.8762.1072.0901.677
Solvency Ratio0.1440.2060.1790.1670.201
Cash Ratio0.7480.1560.2100.0960.074
Price To Earnings Ratio48.01136.16628.63122.33814.778
Price To Earnings Growth Ratio2.8442.4239.305-1.1311.348
Forward Price To Earnings Growth Ratio2.8442.4239.305-1.1311.348
Price To Earnings Diluted Ratio48.14536.28328.63122.33814.778
Price To Earnings Diluted Growth Ratio2.8422.4939.305-1.1311.303
Price To Book Ratio12.8359.4397.5327.0987.085
Price To Sales Ratio4.9483.7732.8162.3792.125
Price To Free Cash Flow Ratio53.59640.03633.095114.48660.209
Price To Operating Cash Flow Ratio32.98224.97519.32921.70511.694
Debt To Assets Ratio0.4720.3680.4400.4920.475
Debt To Equity Ratio1.6350.9771.2961.7221.867
Debt To Capital Ratio0.6200.4940.5640.6330.651
Long Term Debt To Capital Ratio0.6200.4910.5630.6320.651
Financial Leverage Ratio3.4642.6562.9433.5003.926
Working Capital Turnover Ratio4.7596.0185.8986.2217.613
Operating Cash Flow Ratio0.7140.8610.9700.6650.840
Operating Cash Flow Sales Ratio0.1500.1510.1460.1100.182
Free Cash Flow Operating Cash Flow Ratio0.6150.6240.5840.1900.194
Debt Service Coverage Ratio9.1177.8436.9808.17811.497
Interest Coverage Ratio7.3129.6428.1449.5739.672
Short Term Operating Cash Flow Coverage Ratio54.52832.67458.19239.1530.000
Operating Cash Flow Coverage Ratio0.2380.3870.3010.1900.325
Capital Expenditure Coverage Ratio2.6002.6582.4041.2341.241
Dividend Paid And Capex Coverage Ratio1.7321.6881.5390.8760.988
Dividend Payout Ratio0.2800.3130.3460.3400.260
Enterprise Value Multiple31.44023.58718.25715.46011.326

Sparkline shows each ratio oldest → newest (left → right).

How the latest year compares

For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower

MetricCurrentvs 1Y agovs 5Y avg
Gross Profit Margin 22.9% ▼-1.4% ▼-1.7%
Ebit Margin 13.8% ▼-0.5% ▼-2.0%
Ebitda Margin 17.2% ▼-0.3% ▼-1.8%
Operating Profit Margin 10.1% ▼-4.0% ▼-4.2%
Pretax Profit Margin 12.4% ▼-0.4% ▼-1.7%
Continuous Operations Profit Margin 10.3% ▼-0.1% ▼-0.8%
Net Profit Margin 10.3% ▼-0.1% ▼-0.8%
Bottom Line Profit Margin 10.3% ▼-0.1% ▼-0.8%
Current Ratio 2.322 ▲0.361 ▲0.273
Quick Ratio 2.253 ▲0.376 ▲0.252
Solvency Ratio 0.144 ▼-0.061 ▼-0.035
Cash Ratio 0.748 ▲0.592 ▲0.491
Price To Earnings Ratio 48.011 ▲11.845 ▲18.026
Price To Earnings Growth Ratio 2.844 ▲0.421 ▼-0.114
Forward Price To Earnings Growth Ratio 2.844 ▲0.421 ▼-0.114
Price To Earnings Diluted Ratio 48.145 ▲11.861 ▲18.110
Price To Earnings Diluted Growth Ratio 2.842 ▲0.349 ▼-0.120
Price To Book Ratio 12.835 ▲3.397 ▲4.038
Price To Sales Ratio 4.948 ▲1.175 ▲1.740
Price To Free Cash Flow Ratio 53.596 ▲13.560 ▼-6.689
Price To Operating Cash Flow Ratio 32.982 ▲8.007 ▲10.845
Debt To Assets Ratio 0.472 ▲0.104 ▲0.022
Debt To Equity Ratio 1.635 ▲0.658 ▲0.136
Debt To Capital Ratio 0.621 ▲0.126 ▲0.028
Long Term Debt To Capital Ratio 0.621 ▲0.129 ▲0.029
Financial Leverage Ratio 3.464 ▲0.809 ▲0.167
Working Capital Turnover Ratio 4.759 ▼-1.259 ▼-1.343
Operating Cash Flow Ratio 0.714 ▼-0.147 ▼-0.096
Operating Cash Flow Sales Ratio 0.150 ▼-0.001 ▲0.002
Free Cash Flow Operating Cash Flow Ratio 0.615 ▼-0.008 ▲0.174
Debt Service Coverage Ratio 9.117 ▲1.274 ▲0.394
Interest Coverage Ratio 7.312 ▼-2.330 ▼-1.557
Short Term Operating Cash Flow Coverage Ratio 54.528 ▲21.854 ▲17.619
Operating Cash Flow Coverage Ratio 0.238 ▼-0.149 ▼-0.050
Capital Expenditure Coverage Ratio 2.600 ▼-0.058 ▲0.573
Dividend Paid And Capex Coverage Ratio 1.732 ▲0.044 ▲0.367
Dividend Payout Ratio 0.280 ▼-0.033 ▼-0.028
Enterprise Value Multiple 31.440 ▲7.853 ▲11.426

Key metrics

MetricTrend20252024202320222021
Market cap$15.83B$10.20B$7.03B$5.31B$4.51B
Enterprise value$17.34B$11.18B$8.16B$6.56B$5.67B
EV / Sales5.42x4.14x3.27x2.94x2.67x
EV / Op. cash flow36.13x27.38x22.44x26.83x14.69x
EV / Free cash flow58.72x43.89x38.42x141.51x75.62x
EV / EBITDA31.44x23.59x18.26x15.46x11.33x
Net debt / EBITDA2.74x2.07x2.53x2.95x2.31x
Current ratio2.32x1.96x2.18x2.10x1.68x
Income quality1.46x1.45x1.48x1.02x1.26x
Graham number$33$29$25$22$22
Graham net-net-$20-$12-$13-$14-$14
Tax burden82.9%80.9%76.5%75.8%77.3%
Interest burden90.0%89.8%87.2%89.6%91.7%
Working capital$888.3M$455.8M$442.8M$403.8M$314.1M
Invested capital$3.30B$2.19B$2.15B$2.03B$1.83B
Return on assets7.7%9.8%8.9%9.1%12.2%
Operating ROA9.1%13.6%14.3%13.6%14.4%
Return on tangible assets9.6%11.7%10.9%11.2%15.1%
Return on equity26.8%26.1%26.3%31.8%48.0%
Return on invested capital7.4%12.8%12.3%11.7%13.1%
Return on capital employed9.0%15.9%16.1%15.5%16.9%
Earnings yield2.1%2.8%3.5%4.5%6.8%
Free cash flow yield1.9%2.5%3.0%0.9%1.7%
Capex / Op. cash flow38.5%37.6%41.6%81.0%80.6%
Capex / Depreciation169.0%178.9%192.6%268.6%450.3%
Capex / Sales5.8%5.7%6.1%8.9%14.6%
SG&A / Sales12.3%11.8%11.2%10.5%10.8%
R&D / Sales0.4%0.3%0.3%0.4%0.5%
Stock comp / Sales0.8%0.8%0.6%0.6%0.9%
Intangibles / Total assets19.4%15.8%17.6%18.6%18.8%
Days sales outstanding108d103d99d110d118d
Days payables outstanding21d28d25d28d44d
Operating cycle115d110d104d111d118d
Cash conversion cycle94d82d79d83d74d

Change by theme

Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.

Change over 1 year

Valuation
Market cap ▲+55.2%EV / Sales ▲+31.1%EV / EBITDA ▲+33.3%EV / Op. cash flow ▲+8.758Earnings yield ▼-0.007Graham number ▲+4.445
Profitability
Return on equity ▲+0.007Return on assets ▼-0.021Return on invested capital ▼-0.054Return on capital employed ▼-0.069Operating ROA ▼-0.045Income quality ▲+0.008Tax burden ▲+0.020
Efficiency
Days sales outstanding ▲+4.723Days payables outstanding ▼-7.261Operating cycle ▲+4.428Cash conversion cycle ▲+11.690Capex / Sales ▲+0.001R&D / Sales ▲+0.002
Balance-sheet strength
Current ratio ▲+0.361Net debt / EBITDA ▲+0.673Working capital ▲+432541000.000Invested capital ▲+1117548000.000Intangibles / Total assets ▲+0.037

Change over 5 years

Valuation
Market cap ▲+250.6%EV / Sales ▲+103.1%EV / EBITDA ▲+177.6%EV / Op. cash flow ▲+21.448Earnings yield ▼-0.047Graham number ▲+10.826
Profitability
Return on equity ▼-0.213Return on assets ▼-0.045Return on invested capital ▼-0.057Return on capital employed ▼-0.080Operating ROA ▼-0.054Income quality ▲+0.194Tax burden ▲+0.056
Efficiency
Days sales outstanding ▼-9.954Days payables outstanding ▼-23.123Operating cycle ▼-3.740Cash conversion cycle ▲+19.384Capex / Sales ▼-0.089R&D / Sales ▼-0.001
Balance-sheet strength
Current ratio ▲+0.638Net debt / EBITDA ▲+0.435Working capital ▲+574220000.000Invested capital ▲+1473382000.000Intangibles / Total assets ▲+0.006

Employee count

Peer market caps